Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System
Naunyn-Schmiedeberg's archives of pharmacology · 2026 Nov 6 · Wu D, Yang R, Zeng J et
DO
By Daniel Okafor · Regulatory Correspondent
Nov 5 19:00 ETSource: Naunyn-Schmiedeberg's archives of pharmacology
From the source
Read at pubmed.ncbi.nlm.nih.govDisproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System
Naunyn-Schmiedeberg's archives of pharmacology · 2026 Nov 6 · Wu D, Yang R, Zeng J et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42993217/
